rs28365848

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The ENST00000416689.3(SLC2A1-DT):​n.10delT variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 220,588 control chromosomes in the GnomAD database, including 5,620 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4176 hom., cov: 26)
Exomes 𝑓: 0.19 ( 1444 hom. )

Consequence

SLC2A1-DT
ENST00000416689.3 non_coding_transcript_exon

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.718

Publications

3 publications found
Variant links:
Genes affected
SLC2A1-DT (HGNC:44187): (SLC2A1 divergent transcript)
SLC2A1 (HGNC:11005): (solute carrier family 2 member 1) This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]
SLC2A1 Gene-Disease associations (from GenCC):
  • encephalopathy due to GLUT1 deficiency
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • GLUT1 deficiency syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood onset GLUT1 deficiency syndrome 2
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • dystonia 9
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • epilepsy, idiopathic generalized, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary cryohydrocytosis with reduced stomatin
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-42959040-CT-C is Benign according to our data. Variant chr1-42959040-CT-C is described in ClinVar as Benign. ClinVar VariationId is 297392.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A1NM_006516.4 linkc.-390delA upstream_gene_variant ENST00000426263.10 NP_006507.2 P11166Q59GX2
SLC2A1-DTNR_033967.1 linkn.-8delT upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A1ENST00000426263.10 linkc.-390delA upstream_gene_variant 1 NM_006516.4 ENSP00000416293.2 P11166

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35091
AN:
151988
Hom.:
4175
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.162
Gnomad AMR
AF:
0.249
Gnomad ASJ
AF:
0.230
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.208
Gnomad FIN
AF:
0.247
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.210
Gnomad OTH
AF:
0.223
GnomAD4 exome
AF:
0.190
AC:
13033
AN:
68482
Hom.:
1444
Cov.:
0
AF XY:
0.191
AC XY:
7055
AN XY:
36914
show subpopulations
African (AFR)
AF:
0.227
AC:
378
AN:
1668
American (AMR)
AF:
0.204
AC:
374
AN:
1830
Ashkenazi Jewish (ASJ)
AF:
0.195
AC:
446
AN:
2290
East Asian (EAS)
AF:
0.180
AC:
787
AN:
4362
South Asian (SAS)
AF:
0.202
AC:
1658
AN:
8204
European-Finnish (FIN)
AF:
0.208
AC:
728
AN:
3496
Middle Eastern (MID)
AF:
0.201
AC:
66
AN:
328
European-Non Finnish (NFE)
AF:
0.185
AC:
7829
AN:
42280
Other (OTH)
AF:
0.191
AC:
767
AN:
4024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
509
1017
1526
2034
2543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.231
AC:
35119
AN:
152106
Hom.:
4176
Cov.:
26
AF XY:
0.234
AC XY:
17403
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.258
AC:
10702
AN:
41490
American (AMR)
AF:
0.249
AC:
3815
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.230
AC:
797
AN:
3468
East Asian (EAS)
AF:
0.228
AC:
1177
AN:
5152
South Asian (SAS)
AF:
0.209
AC:
1008
AN:
4828
European-Finnish (FIN)
AF:
0.247
AC:
2623
AN:
10600
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.210
AC:
14294
AN:
67960
Other (OTH)
AF:
0.225
AC:
475
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1380
2760
4140
5520
6900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0646
Hom.:
138
Bravo
AF:
0.230
Asia WGS
AF:
0.243
AC:
845
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dystonia 9 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Encephalopathy due to GLUT1 deficiency Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Childhood onset GLUT1 deficiency syndrome 2 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jun 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

GLUT1 deficiency syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dystonic disorder Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cryohydrocytosis with reduced stomatin Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, idiopathic generalized, susceptibility to, 12 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.72
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28365848; hg19: chr1-43424711; API